References
- 1
Frohman E M, Racke M K, Raine C S.
Multiple sclerosis - the plaque and its pathogenesis.
N Engl J Med.
2006;
354
942-955
- 2
Noseworthy J H, Lucchinetti C, Rodriguez M, Weinshenker B G.
Multiple sclerosis.
N Engl J Med.
2000;
343
938-952
- 3
Sospedra M, Martin R.
Immunology of multiple sclerosis.
Annu Rev Immunol.
2005;
23
683-747
- 4
Duquette P, Murray T J, Pleines J, Ebers G C, Sadovnick D, Weldon P, Warren S, Paty D W,
Upton A, Hader W. et al .
Multiple sclerosis in childhood: clinical profile in 125 patients.
J Pediatr.
1987;
111
359-363
- 5
Ghezzi A, Deplano V, Faroni J, Grasso M G, Liguori M, Marrosu G, Pozzilli C, Simone I L,
Zaffaroni M.
Multiple sclerosis in childhood: clinical features of 149 cases.
Mult Scler.
1997;
3
43-46
- 6
Boiko A, Vorobeychik G, Paty D, Devonshire V, Sadovnick D.
Early onset multiple sclerosis: a longitudinal study.
Neurology.
2002;
59
1006-1010
- 7
Banwell B, Reder A T, Krupp L, Tenembaum S, Eraksoy M, Alexey B, Pohl D, Freedman M,
Schelensky L, Antonijevic I.
Safety and tolerability of interferon beta-1b in pediatric multiple sclerosis.
Neurology.
2006;
66
472-476
- 8
Pakdaman H, Fallah A, Sahraian M A, Pakdaman R, Maysami P.
Treatment of early onset multiple sclerosis with suboptimal dose of interferon beta
1a.
Neuropediatrics.
2006;
37
257-260
MD Alireza Minagar
Dept. Neurology
Louisiana State University Health Sciences Center
1501 Kings Highway
Shreveport, LA 71130
USA
Email: aminag@lsuhsc.edu